BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34661140)

  • 1. The Genomic Landscape of HIV-Associated Plasmablastic Lymphoma.
    Küppers R
    Blood Cancer Discov; 2020 Jul; 1(1):23-25. PubMed ID: 34661140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.
    Liu Z; Filip I; Gomez K; Engelbrecht D; Meer S; Lalloo PN; Patel P; Perner Y; Zhao J; Wang J; Pasqualucci L; Rabadan R; Willem P
    Blood Cancer Discov; 2020 Jul; 1(1):112-125. PubMed ID: 33225311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
    Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
    Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
    Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
    Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphoma: from genetics to treatment.
    Frontzek F; Hailfinger S; Lenz G
    Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.
    Frontzek F; Staiger AM; Zapukhlyak M; Xu W; Bonzheim I; Borgmann V; Sander P; Baptista MJ; Heming JN; Berning P; Wullenkord R; Erdmann T; Lutz M; Veratti P; Ehrenfeld S; Wienand K; Horn H; Goodlad JR; Wilson MR; Anagnostopoulos I; Lamping M; Gonzalez-Barca E; Climent F; Salar A; Castellvi J; Abrisqueta P; Menarguez J; Aldamiz T; Richter J; Klapper W; Tzankov A; Dirnhofer S; Rosenwald A; Mate JL; Tapia G; Lenz P; Miething C; Hartmann W; Chapuy B; Fend F; Ott G; Navarro JT; Grau M; Lenz G
    Nat Commun; 2021 Aug; 12(1):5183. PubMed ID: 34465776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
    Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
    Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
    Leeman-Neill RJ; Soderquist CR; Montanari F; Raciti P; Park D; Radeski D; Mansukhani MM; Murty VV; Hsiao S; Alobeid B; Bhagat G
    Haematologica; 2022 Jan; 107(1):201-210. PubMed ID: 33297669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.
    Montes-Moreno S; Martinez-Magunacelaya N; Zecchini-Barrese T; Villambrosía SG; Linares E; Ranchal T; Rodriguez-Pinilla M; Batlle A; Cereceda-Company L; Revert-Arce JB; Almaraz C; Piris MA
    Mod Pathol; 2017 Jan; 30(1):85-94. PubMed ID: 27687004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Loghavi S; Gomez Mediavilla A; Tonda R; Beltran S; Gut M; Pereña Gonzalez A; d'Ámore E; Visco C; Khoury JD; Montes-Moreno S
    Haematologica; 2021 Apr; 106(4):1120-1128. PubMed ID: 32273478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
    Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
    Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
    Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
    Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's Plasmablastic Lymphoma as Initial Presentation of Human Immunodeficiency Virus.
    Jariwal R; Raza N; Bhandohal J; Cobos E
    J Investig Med High Impact Case Rep; 2021; 9():23247096211014689. PubMed ID: 33980062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity.
    Mota F; Mesquita B; Carvalho S; Coelho A; Velho G; Lima M; Selores M
    Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmablastic lymphoma: a case of rectal disease with bone marrow involvement in a HIV positive patient].
    García Chihuan G; Fernández Butrón A; Salazar Alejo R; Frisancho O; Beltrán B
    Rev Gastroenterol Peru; 2014; 34(4):347-50. PubMed ID: 25594760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human immunodeficiency virus and lymphoma].
    Tazi I; Lahlimi FZ
    Bull Cancer; 2021 Oct; 108(10):953-962. PubMed ID: 34246454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
    Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
    Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.